Petition to the UN in support of embryonic stem cell research signed by 29 Nobel Laureates

    26 June 2014: SCNT Breakthrough (from NYSCF on Vimeo)

    As reported on 5 October 2011 in Nature, for the first time scientists used therapeutic cloning, known technically as somatic cell nuclear transfer (or SCNT), to create embryonic stem cells. The advance moved scientists one step closer to their goal of developing therapies to treat maladies including diabetes, Alzheimer’s disease and Parkinson’s disease, researchers said.

    “This paper will be seen as significant both by those who are trying to use SCNT to produce human patient-specific embryonic stem cell lines and by those who oppose human ‘cloning’ experiments,” said Professor Robin Lovell-Badge, a division head at Britain’s National Institute for Medical Research.

    The development in New York marked a landmark in stem cell study, but also represented a new flashpoint for opponents of SCNT, and other forms of embryonic stem cell research. Click on the link below to urge the United Nations to establish a timetable for a declaration on human cloning for therapeutic reasons. The text of the 2005 United Nations Declaration on Human Cloning deliberately blurs the line separating reproductive and therapeutic cloning, and lends itself to the interpretation that the world body has called for a ban of therapeutic cloning, a point not conceded by states voting against and abstaining from the declaration.

    Hear about NYSCF’s 2014 SCNT breakthrough in the video above. And click here to sign the petition at GoPetition!

    Read NYSCF’s Press Release >>

    Read NYSCF’s paper in Nature >>

    Read more about NYSCF’s breakthrough in The Wall Street Journal >>

    Read more about NYSCF’s breakthrough in Time >>

    Our petition has been signed by more than 600 scientists and scholars from around the world, including 29 Nobel Laureates, 13 US National Medal of Science winners, seven UK Royal Medal winners, five Lasker Award winners and three winners of the Israeli Wolf Prize.

    Notable signatories on the petition include the following Nobel Laureates:

    Sidney Altman, Chemistry, 1989
    Kenneth J. Arrow,* Economics, 1972
    Paul Berg,* Chemistry, 1980
    Günter Blobel, Physiology or Medicine, 1999
    Sir Sydney Brenner, Physiology or Medicine, 2002
    Elias J. Corey,* Chemistry, 1990
    Christian de Duve, Physiology or Medicine, 1974
    John B. Fenn, Chemistry, 2002
    Edmond H. Fischer, Physiology or Medicine, 1992
    Jerome Friedman, Physics, 1990
    Ivar Giaever, Physics, 1973
    Walter Gilbert, Chemistry, 1980
    Sir Clive Granger, Economics, 2003
    Paul Greengard, Physiology or Medicine, 2000
    Sir John Gurdon, Physiology or Medicine, 2012
    Sir Tim Hunt, Physiology or Medicine, 2001
    Sir Aaron Klug, Chemistry, 1982
    Edwin Krebs, Physiology or Medicine, 1992
    Jean-Marie Lehn, Chemistry, 1987
    Rudolph A. Marcus,* Chemistry, 1992
    Ferid Murad, Physiology or Medicine, 1998
    Marshall Nirenberg,* Physiology or Medicine, 1968
    Sir Paul Nurse, Physiology or Medicine, 2001
    Christiane Nüsslein-Volhard, Physiology or Medicine, 1995
    Douglas D. Osheroff, Physics, 1996
    David Politzer, Physics, 2004
    Sir John Walker, Chemistry, 1997
    Eric Wieschaus, Physiology or Medicine, 1995
    Torsten Wiesel,* Physiology or Medicine, 1981

    The following distinguished scientists and scholars have signed the petition:

    It is recognized that the views expressed in the petition represent those of the signers acting as individual citizens. They do not necessarily represent the views of the institutions with which they are affiliated.

    Qais Al-Awqati, Columbia University, USA
    Kari Alitalo, University of Helsinki, Finland
    C. David Allis, Rockefeller University, USA
    Herwig Baier, Max Planck Institute, Germany
    Etienne E. Baulieu, University of Paris-Sud 11, France
    Aaron T. Beck, University of Pennsylvania, USA
    Jean-Paul Behr, University of Strasbourg, France
    Sir John Bell, University of Oxford, UK
    Colin Blakemore, University of Oxford, UK
    Robert Braun, The Jackson Laboratory, USA
    Sir Martin Bobrow, University of Cambridge, UK
    Sir Walter Bodmer, University of Oxford, UK
    Sir Christopher Booth, University College London, UK
    Arthur Caplan, University of Pennsylvania, USA
    Manuel Castells, University of California, Berkeley, USA
    Jean-Pierre Changeux, Collège de France, France
    Noam Chomsky, Massachusetts Institute of Technology, USA
    George Church, Harvard University, USA
    William Danforth, Washington University, USA
    James E. Darnell,* Rockefeller University, USA
    HongKui Deng, Peking University, China
    Jack E Dixon, University of California, San Diego, USA
    Anna Dominiczak, University of Glasgow, UK
    Ronald Evans, Salk Institute, USA
    Gerald D. Fischbach, Columbia University, USA
    Elaine Fuchs,* Rockefeller University, USA
    Fred H. Gage, Salk Institute for Biological Studies, USA
    Sir Richard Gardner, University of Oxford, UK
    Emil Gotschlich, Rockefeller University, USA
    Sir John Harris, University of Manchester, UK
    Leonard Hayflick, University of California, San Francisco, USA
    Sir David Hopwood, Norwich Research Park, UK
    Sir Gabriel Horn, University of Cambridge, UK
    Tony Hunter, Salk Institute, USA
    Rudolf Jaenisch,* Massachusetts Institute of Technology, USA
    Hans Keirstead, University of California, Irvine, USA
    Douglas Kell, Biotechnology and Biological Sciences Research Council, UK
    Irina Kerkis, Butantan Institute, Brazil
    Sir David J. Kerr, University of Oxford, UK
    John A. Kessler, Northwestern University, USA
    Sir David King, University of Oxford, UK
    Sir Hans Kornberg, Boston University, USA
    Lawrence M. Krauss, Case Western Reserve University, USA
    Sir Peter Lachmann, University of Cambridge, UK
    Robert Lanza, Advanced Cell Technology, USA
    Ruth Lehmann, New York University, USA
    Ihor Lemischka, Mount Sinai School of Medicine, USA
    Olle Lindvall, Lund University, Sweden
    Stuart Lipton, Sanford-Burnham Medical Research Institute, USA
    Nikos Logothetis, Max Planck Institute, Germany
    Robin Lovell-Badge, MRC National Institute for Medical Research, UK
    Jennifer Marshall Graves, The Australian National University, Australia
    Chris Mason, University College London, UK
    Bruce McEwen, Rockefeller University, USA
    Sir Andrew McMichael, University of Oxford, UK
    Mark Mercola, Sanford-Burnham Medical Research Institute, USA
    Stephen Minger, GE Healthcare, UK
    Andras Nagy, Samuel Lunenfeld Research Institute, Canada
    Mark Noble, University of Rochester, USA
    Jan Nolta, University of California, Davis, USA
    Leena Peltonen-Palotie, Wellcome Trust Sanger Institute, UK
    Stephen Pinker, Harvard University, USA
    Dame Julia Polak, Imperial College London, UK
    Barry Posner OC, McGill University, Canada
    Peter H. Raven,* Washington University, USA
    Brock Reeve, Harvard University, USA
    Benjamin Reubinoff, Hadassah University, Israel
    Alexander Rich,* Massachusetts Institute of Technology, USA
    Hans Schöler, Max Planck Institute, Germany
    Wolfgang Schomburg, Former Judge od ICTY and ICTR, Germany
    Andrew Sessler, University of California, Berkeley, USA
    Lee Silver, Princeton University, USA
    Kai Simons, Max Planck Institute, Germany
    Peter Singer, Princeton University, USA
    Douglas Sipp, RIKEN Center for Developmental Biology, Japan
    Jonathan Slack, University of Minnesota, USA
    Lorenz Studer, Memorial Sloan-Kettering Cancer Centre, USA
    Samuel Stupp, Northwestern University, USA
    Azim Surani CBE, University of Cambridge, UK
    Sir Richard Sykes, Imperial College London, UK
    Evan Synder, Burham Institute for Medical Research, USA
    John Urquhart, University of California, San Francisco, USA
    Baron Marc Van Montagu, Ghent University, Belgium
    Craig J. Venter,* J. Craig Venter Institute, USA
    Umberto Veronesi, European Institute of Oncology, Italy
    David Ward, Nevada Cancer Institute, USA
    Gerald J. Wasserburg, California Institute of Technology, USA
    Irving Weissman, Stanford University, USA
    Sir Ian Wilmut, University of Edinburgh, UK
    Lord Robert Winston, Imperial College London, UK
    Rick Woychik, National Institute of Environmental Health Sciences, USA
    Huanming Yang, Beijing Genomics Institute, China
    Charles Yanofsky,* Stanford University, USA
    Axel R. Zander, University of Hamburg, Germany
    Philip Zimbardo, Stanford University, USA

    *US National Medal of Science


    1. Obviously a powerful endorsement of the scientific method which should any discussion of such an important new area of research. I recently was privileged to visit the UC San Francisco stem cell department where a briefing by its head person provided up to date information about where stem cell research now stands.

      I was told that there is alot of false information going around, some from unscrupulous providers to patients desperate for treatments which are more likely to be unhelpful and even dangerous.

    2. All hats off to the brave men and women who have worked so hard to develop cures for those afflicted with heinous diseases that can ONLY be cured by the discarded cells of fetuses by mothers desiring for good reason to terminate their pregnancy.

    3. The politically motivated religious and cultural conservatives often located in positions of political power many times retard real scientific progress.

    4. Why in heavens name aren't we doing more in the field of medical research? Oh, I forgot, the GOP controls the purse strings … would rather fuss over ACA.